Login

Healthcare

00:00:00
4D Pharma raises $40 million - Duncan Peyton, CEO, 4D Pharma
00:10:00
CEO Spotlight: Leadership Insights from Jason C. Foster of Ori Biotech | JASON C. FOSTER , CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR OF ORI BIOTECH
00:10:00
NC BioTech CEO Doug Edgeton on Life Sciences Innovations | DOUG EDGETON, PRESIDENT AND CEO OF NORTH CAROLINA BIOTECHNOLOGY CENTER
00:10:00
Pan-Amyloid Removal Therapeutics by Attralus: A Novel Approach to Systemic Amyloidosis | Mark Timney, CHIEF EXECUTIVE OFFICER, ATTRALUS
00:10:00
The goal of drug developer Atossa Therapeutics is to "transform the breast cancer paradigm." | Steven C. Quay, CEO, ATOSSA THERAPEUTICS INC
00:10:00
Financial results for the entire year 2021: Pascal Soriot, CEO | Pascal Soriot, CEO OF AstraZeneca INC
00:10:00
Bill Rancic and Mark Reisenauer Talk About the C3 Award for Cancer Innovation | Mark Reisenauer, PRESIDENT, ASTELLAS PHARMA US, INC
00:10:00
Online viralgen new facilities sub-eng sin band 1 | Gustavo Pesquin, CEO, ASKLEPIOS BIOPHARMACEUTICAL, INC.
00:10:00
Stock News Now for Ascletis Pharma Inc. (HKEX: 1672) | Jinzi J. Wu, PhD , CEO, ASCLETIS PHARMA INC
00:10:00
Clarivate assists clients in finding, safeguarding, and promoting their inventions | JONATHAN GEAR, CEO, Clarivate PLC
00:10:00
Global Commerce with Kathy Ireland®-Advances in Incontinence Management with Dr. Karen Noblett | Raymond W. Cohen, CHIEF EXECUTIVE OFFICER, AXONICS INC
00:10:00
Neurosciences Avidity - Myotonic Dystrophy | SARAH BOYCE, PRESIDENT & CHIEF EXECUTIVE, FICER OF AVIDITY BIOSCIENCES INC
00:10:00
Biogen CEO on Revolutionizing Drug Development for Rare Diseases with n-Lorem | CHRISTOPHER A. VIEHBACHER, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BIOGEN
00:10:00
Navigating Complex Pipelines and Scalable Manufacturing Platforms| ALESSANDRO MASELLI , CHIEF EXECUTIVE OFFICER OF CATALENT
00:10:00
ZyVersa Therapeutics Pioneer Breakthroughs in Inflammatory and Kidney Disease Treatment | STEPHEN C. GLOVER , CO-FOUNDER, CHIEF EXECU TIVE OFFICER, AND CHAIRMAN OF ZYVERSA THERAPEUTICS INC
00:10:00
Zynerba Pharmaceuticals Bolsters IP Portfolio for Zygel, Revolutionary Cannabidiol Clear Gel with Enhanced Transdermal Delivery| ARMANDO ANIDO , CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER OF ZYNERBA PHARMACEUTICALS, INC

© 2026 Nehu